Meridian Clinical Research, a leading multi-specialty investigative research site network, has acquired North Cliff Consultants, a leader in contract testing services for consumer product manufacturers and retailers.
North Cliff, which has been in business for more than 35 years, has two sites within the Greater Cincinnati area, including West Price Hill (3747 Warsaw Ave, Cincinnati, OH 45205) and Colerain (6831 Colerain Ave, Cincinnati, OH 45239). The company is well-known for designing and conducting studies to gather meaningful and accurate data and consumer feedback. North Cliff has long provided clinical and sensory testing services to pharmaceutical and medical device developers, as well as contract services for developers, manufacturers, and retailers of consumer products, foods, fragrances, and other household goods.
Meridian partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics that could improve human health and wellbeing. With this acquisition, Meridian will expand its consumer product and personal care product research capabilities with the addition of North Cliff’s two sites.
Nicole Osborn, Founder and CEO of Meridian, said the acquisition will leverage North Cliff’s exceptional consumer research experience to serve companies that rely on robust clinical testing and consumer sentiment data to bring their products to market.
“Increasingly, Meridian’s partners are creating products that go beyond traditional healthcare products — this includes combination products, mobile applications, wearable tech, and over-the-counter consumer goods,” said Osborn.
“This acquisition addresses a growing need for consumer use and preference research that can dovetail into larger clinical trial and R&D programs.”
“Working with Meridian will bring additional resources and expertise to North Cliff while bringing more choices and opportunities to our valued participants,” said Paul McOsker, President of North Cliff Consultants. “We are excited to connect our participants with clinical trials, while also helping Meridian expand its reach in consumer product testing. Together, we’ll help drive the next generation of safe and effective products.”
Meridian now has 35 investigative research sites nationwide. Since opening in Omaha in 1999, Meridian has enrolled more than 85,000 patients in 3,400 clinical trials.
If you’re interested in joining a clinical trial at Meridian or want to sign up to learn about upcoming studies, visit mcrmed.com/find-study.
People interested in studies at North Cliff — including studies that involve testing products from home — can sign up for more information at northclifftesting.com.
ABOUT MERIDIAN CLINICAL RESEARCH
Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is a multi-specialty site network headquartered at its dedicated research center in Omaha, NE, and conducts Phase 1-4 clinical trials at investigative sites nationwide. Meridian supports research across numerous therapeutic areas and excels in high-volume vaccine trials. For more information, visit mcrmed.com.
Meridian Clinical Research